Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 18/9/2019
SIETES contiene 92806 citas

 1 a 15 de 15 
Presentar resultados
Seleccionar todas
2. Cita con resumen
Greene JA, Riggs KR. Why is there no generic insulin? Historical origins of a modern problem. N Engl J Med 2015;372:1171-5. [Ref.ID 98966]
3. Cita con resumen
Tricco AC, Ashoor HM, Antony J, Beyene J, Veroniki AA, Isaranuwatchai W, Harrington A, Wilson C, Tsouros S, Soobiah C, Yu CH, Hutton B, Hoch JS, Hemmelgarn BR, Moher D, Majumdar SR, Straus SE. Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis. BMJ 2014;349:g5459. [Ref.ID 98278]
4.Enlace a cita originalTiene citas relacionadas Cita con resumen
Sumeet R, Ahmad F, Lal A, Yu C, Bai Z, Bennett H. Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis. Can Med Assoc J 2009;180:385-97. [Ref.ID 85432]
5.Enlace a cita originalTiene citas relacionadas
Siebenhofer-Kroitzsch A, Horvath K, Plank J. Insulin analogues: too much noise about small benefits. Can Med Assoc J 2009;180:369-70. [Ref.ID 85431]
6.Enlace a cita original Cita con resumen
Cameron CG, Bennett HA. Cost-effectiveness of insulin analogues for diabetes mellitus. Can Med Assoc J 2009;180:400-7. [Ref.ID 85430]
7.Tiene citas relacionadas
Majumdar S, Barrett E. Newer insulins in search of a niche. Ann Intern Med 2008;149:586-8. [Ref.ID 84339]
8.Tiene citas relacionadas
Qayyum R, Bolen S, Maruthur N, Feldman L, Wilson LM, Marinopoulos SS, Ransinghe P, Amer M, Bass EB. Systematic review: Comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes. Ann Intern Med 2008;149:549-59. [Ref.ID 84338]
9.Tiene citas relacionadas Cita con resumen
Esposito K, Ciotola M, Mariorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control. A randomized trial. Ann Intern Med 2008;149:531-9. [Ref.ID 84337]
Anónimo. Insuline lispro en mélange. Un gain minime en termes de confort. Prescrire 2003;23:174-5. [Ref.ID 65275]
12.Tiene citas relacionadas
Norris A W, Laffel LMB. Avoiding nocturnal hypoglycemia: consideration of an extra injection at bedtime. Ann Intern Med 2002;136:547-9. [Ref.ID 61571]
13.Tiene citas relacionadas
Fanelli CG, Pampanelli S, Porcellati F, Rossetti P, Brunetti P, Bolli GB. Administration of neutral protamine hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. Ann Intern Med 2002;136:504-14. [Ref.ID 61567]
14. Cita con resumen
Owens DR, Zinman B, Bolli GB. Insulins today and beyond. Lancet 2001;358:739-46. [Ref.ID 58346]
15. Cita con resumen
Laubach E, Schwandt P, Ritter M M. Neutral protamine Hagedorn insulin. Lancet 2000;355:236. [Ref.ID 48838]
Seleccionar todas
 1 a 15 de 15